{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:46:30Z","timestamp":1775058390515,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"grants of National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82360226"],"award-info":[{"award-number":["82360226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Huai'an City Municipal Science and Technology Plan","award":["HAB202210"],"award-info":[{"award-number":["HAB202210"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-025-02220-x","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T06:46:41Z","timestamp":1765176401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Harnessing machine learning for the development, validation, and prognostic evaluation of MASHRisk score: insights from a multicohort study"],"prefix":"10.1038","volume":"9","author":[{"given":"Bicheng","family":"Ye","sequence":"first","affiliation":[]},{"given":"Yuming","family":"Teng","sequence":"additional","affiliation":[]},{"given":"Qianqian","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Shun","family":"Li","sequence":"additional","affiliation":[]},{"given":"Li","family":"Dong","sequence":"additional","affiliation":[]},{"given":"Changan","family":"Xu","sequence":"additional","affiliation":[]},{"given":"Xiao","family":"Qiao","sequence":"additional","affiliation":[]},{"given":"Xiaye","family":"Miao","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"2220_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","volume":"6","author":"G Targher","year":"2021","unstructured":"Targher, G., Tilg, H. & Byrne, C. D. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol. Hepatol. 6, 578\u2013588 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2220_CR2","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","volume":"70","author":"TG Simon","year":"2021","unstructured":"Simon, T. G., Roelstraete, B., Khalili, H., Hagstr\u00f6m, H. & Ludvigsson, J. F. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. Gut 70, 1375\u20131382 (2021).","journal-title":"Gut"},{"key":"2220_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"2220_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/nrgastro.2016.3","volume":"13","author":"ME Rinella","year":"2016","unstructured":"Rinella, M. E. & Sanyal, A. J. Management of NAFLD: a stage-based approach. Nat. Rev. Gastroenterol. Hepatol. 13, 196\u2013205 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2220_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani, N. et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67, 328\u2013357 (2018).","journal-title":"Hepatology"},{"key":"2220_CR6","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/gutjnl-2020-321299","volume":"69","author":"J Neuberger","year":"2020","unstructured":"Neuberger, J. et al. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut 69, 1382\u20131403 (2020).","journal-title":"Gut"},{"key":"2220_CR7","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","volume":"5","author":"PN Newsome","year":"2020","unstructured":"Newsome, P. N. et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol. Hepatol. 5, 362\u2013373 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2220_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S2468-1253(20)30252-1","volume":"5","author":"SA Harrison","year":"2020","unstructured":"Harrison, S. A. et al. A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol. Hepatol. 5, 970\u2013985 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2220_CR9","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1016\/S2589-7500(23)00245-5","volume":"6","author":"G Cai","year":"2024","unstructured":"Cai, G. et al. Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study. Lancet Digit. Health 6, e176\u2013e186 (2024).","journal-title":"Lancet Digit. Health"},{"key":"2220_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener, J. G., Kandathil, S. M., Moffat, L. & Jones, D. T. A guide to machine learning for biologists. Nat. Rev. Mol. Cell Biol. 23, 40\u201355 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2220_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i11","volume":"36","author":"MB Kursa","year":"2010","unstructured":"Kursa, M. B. & Rudnicki, W. R. Feature Selection with the Boruta Package. J. Stat. Softw. 36, 1\u201313 (2010).","journal-title":"J. Stat. Softw."},{"key":"2220_CR12","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","volume":"83","author":"GR Steinberg","year":"2025","unstructured":"Steinberg, G. R., Valvano, C. M., De Nardo, W. & Watt, M. J. Integrative metabolism in MASLD and MASH: pathophysiology and emerging mechanisms. J. Hepatol. 83, 584\u2013595 (2025).","journal-title":"J. Hepatol."},{"key":"2220_CR13","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.cmet.2023.10.009","volume":"35","author":"K Sawada","year":"2023","unstructured":"Sawada, K., Chung, H., Softic, S., Moreno-Fernandez, M. E. & Divanovic, S. The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease. Cell Metab. 35, 1852\u20131871 (2023).","journal-title":"Cell Metab."},{"key":"2220_CR14","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s11883-023-01167-2","volume":"25","author":"B Nussbaumerova","year":"2023","unstructured":"Nussbaumerova, B. & Rosolova, H. Obesity and dyslipidemia. Curr. Atheroscler. Rep. 25, 947\u2013955 (2023).","journal-title":"Curr. Atheroscler. Rep."},{"key":"2220_CR15","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005\u20132023 (2012).","journal-title":"Hepatology"},{"key":"2220_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59183-4","volume":"14","author":"B Njei","year":"2024","unstructured":"Njei, B., Osta, E., Njei, N., Al-Ajlouni, Y. A. & Lim, J. K. An explainable machine learning model for prediction of high-risk nonalcoholic steatohepatitis. Sci. Rep. 14, 8589 (2024).","journal-title":"Sci. Rep."},{"key":"2220_CR17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3748\/wjg.v30.i7.652","volume":"30","author":"QJ He","year":"2024","unstructured":"He, Q. J. et al. Recent advances in age-related metabolic dysfunction-associated steatotic liver disease. World J. Gastroenterol. 30, 652\u2013662 (2024).","journal-title":"World J. Gastroenterol."},{"key":"2220_CR18","doi-asserted-by":"crossref","unstructured":"Crommen, S. et al. Prognostic characteristics of metabolic dysfunction-associated steatotic liver in patients with obesity who undergo one anastomosis gastric bypass surgery: a secondary analysis of randomized controlled trial data. Nutrients 16, 3210 (2024).","DOI":"10.3390\/nu16183210"},{"key":"2220_CR19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7, 851\u2013861 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2220_CR20","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/hep.28390","volume":"63","author":"A Unalp-Arida","year":"2016","unstructured":"Unalp-Arida, A. & Ruhl, C. E. Noninvasive fatty liver markers predict liver disease mortality in the U.S. population. Hepatology 63, 1170\u20131183 (2016).","journal-title":"Hepatology"},{"key":"2220_CR21","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/apt.14967","volume":"48","author":"A Unalp-Arida","year":"2018","unstructured":"Unalp-Arida, A. & Ruhl, C. E. Liver fat scores predict liver disease mortality in the United States population. Aliment Pharmacol. Ther. 48, 1003\u20131016 (2018).","journal-title":"Aliment Pharmacol. Ther."},{"key":"2220_CR22","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jhep.2024.10.015","volume":"82","author":"Q Huang","year":"2025","unstructured":"Huang, Q. et al. A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease. J. Hepatol. 82, 781\u2013793 (2025).","journal-title":"J. Hepatol."},{"key":"2220_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cmet.2024.10.008","volume":"37","author":"X Zhang","year":"2025","unstructured":"Zhang, X. et al. A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis. Cell Metab. 37, 59\u201368.e53 (2025).","journal-title":"Cell Metab."},{"key":"2220_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jhep.2025.01.026","volume":"83","author":"E Pose","year":"2025","unstructured":"Pose, E. et al. Moving diagnosis of liver fibrosis into the community. J. Hepatol. 83, 258\u2013270 (2025).","journal-title":"J. Hepatol."},{"key":"2220_CR25","doi-asserted-by":"crossref","unstructured":"Adams, L. A., Thiele, M. & Tsochatzis, E. A. Detecting at-risk steatotic liver disease and liver fibrosis in the community. Hepatology (2025).","DOI":"10.1097\/HEP.0000000000001400"},{"key":"2220_CR26","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang, S. et al. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 53, D1670\u2013d1676 (2025).","journal-title":"Nucleic Acids Res."},{"key":"2220_CR27","doi-asserted-by":"publisher","first-page":"eadh9940","DOI":"10.1126\/scitranslmed.adh9940","volume":"16","author":"J Ding","year":"2024","unstructured":"Ding, J. et al. Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population. Sci. Transl. Med. 16, eadh9940 (2024).","journal-title":"Sci. Transl. Med."},{"key":"2220_CR28","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321 (2005).","journal-title":"Hepatology"},{"key":"2220_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn, M. Building predictive models in R using the Caret package. J. Stat. Softw. 28, 1\u201326 (2008).","journal-title":"J. Stat. Softw."},{"key":"2220_CR30","unstructured":"Lundberg, S. M. & Lee, S.-I. A unified approach to interpreting model predictions. In Proc. 31st International Conference on Neural Information Processing Systems 4768\u20134777 (Curran Associates Inc., 2017)."},{"key":"2220_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"2220_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"2220_CR33","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02220-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02220-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02220-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:43:57Z","timestamp":1768401837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02220-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2220"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-02220-x","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}